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Abstract The Expanded Disability Status Scale (EDSS)
is the current ‘gold standard’ for monitoring disease
severity in multiple sclerosis (MS). The EDSS is a physi-
cian-based assessment. A patient-related surrogate for the
EDSS may be useful in remotely capturing information.
Eighty-one patients (EDSS range 0–8) having EDSS as part
of clinical trials were recruited. All patients carried out the
web-based survey with minimal assistance. Full EDSS
scores were available for 78 patients. The EDSS scores
were compared to those generated by the online survey
using analysis of variance, matched pair test, Pearson’s
coefficient, weighted kappa coefficient, and the intra-class
correlation coefficient. The internet-based EDSS scores
showed good correlation with the physician-measured
assessment (Pearson’s coefficient = 0.85). Weighted
kappa for full agreement was 0.647. Full agreement was
observed in 20 patients who had EDSS scores ranging from
0 to 6; many of those with 100 % agreement had scores of
5.5–6 (n = 8).The intra-class coefficient was 0.844 overall
for all cases. Internet-based FS and EDSS show good
agreement with physician-measured scores. Agreement
was better in patients with higher scores. Overall patient
satisfaction with the web-based assessment was high. An
internet-based assessment tool is likely to prove an
invaluable tool in the long-term monitoring in MS.
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Introduction
The Disability Status Scale (DSS) was first devised by
Kurtzke [1] in 1955 to address the lack of a valid method
for the measurement of disease progression in patients with
multiple sclerosis (MS). The revised form, the Expanded
Disability Status Scale (EDSS) was introduced in 1983 [2].
The EDSS is currently the gold standard method for
assessing both the extent and progression of disability in
patients with multiple sclerosis (MS) [2].
The EDSS is a physician-led examination which asses-
ses eight functional systems (FS) commonly affected by
MS; these are cerebellar, pyramidal, sensory, bowel and
bladder, visual, brainstem, mental or cognitive function and
mobility [1]. The original scale included 11 stages of dis-
ease progression, with 0 being a normal neurological
examination and 10 being death due to MS; the expansion
of the scale included half steps in order to increase sensi-
tivity to changes in disease progression [3]. Grades from 0
to 3.5 reflect impairments of the FS, while midscale scores
from 4.0 to 7.0 are the result of difficulties in ambulation,
with less emphasis on the FS score. Higher scores reflect
more severe disabilities, focussing on the need for assis-
tance and difficulties with communication and feeding [4].
Although widely used by clinicians, the EDSS has been
criticised for being physician led, difficult to reproduce and
relatively insensitive to change as the disease progresses
[4–10]. Several studies have examined the efficacy of
patient led assessment of disease progression via telephone
and self-report questionnaires. [11, 13] The need for long
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term follow-up in clinical trials means that an internet-
based version of the EDSS is likely to provide a valuable
method for assessing patients remotely. As widespread
internet access increases, patients previously unable to
undergo regular assessments for practical reasons can be
easily accessed. An internet-based assessment tool is likely
to prove an invaluable tool in the long-term monitoring in
MS; not least for those patients who have difficulty trav-
elling to see physicians regularly due to the severity of their
disease.
Materials and methods
Study design
This study was an early stage, proof-of concept study.
Patients who were having their EDSS measured at the
Royal London Hospital, as part of clinical research proto-
cols, were recruited. Patients were required to have clini-
cally definite MS, be able to read English and be aged over
18. Patients were first seen by their assessing physician for
EDSS; they then completed the online assessment.
Demographic details including gender, age, ethnicity, year
of first MS symptoms, year of diagnosis, disease modifying
therapy where known (some patients were taking part in
clinical trials), previous EDSS and number of relapses were
also recorded. This study had ethical approval from the
North London REC 2 (ref 10/H0724/27).
Both the physician assessment and online assessment
were completed during the same visit. The assessing phy-
sician was aware that the web-EDSS study was being
performed, but was not informed of the scores generated by
the online assessment. The patient was also unaware of the
scores generated by their completion of the assessment.
Description of online assessment
The web based EDSS calculator is based on the telephone-
based assessment developed by Lechner-Scott et al. [11],
and the interface was generated using Survey Monkey.
Each patient was given a unique username during the
consent process, and all questionnaires were filled in using
this. A list of the questions included within the question-
naire is given in supplementary appendix 1. The questions
were designed to mirror the FS scores within the EDSS,
with care taken to ensure the language was suitable for a
lay audience. An FS score was generated for each system
using the responses gathered, and from this the overall
EDSS was calculated.
As not all questions within the EDSS are relevant to all
patients, and indeed some patients with early MS may find
questions regarding higher EDSS steps distressing, the
questionnaire ensured that not all patients were asked all
questions. Care was taken to ensure that patients were not
asked similar or identical questions repeatedly. This was
achieved through the use of logic built into the question-
naire. This meant that each patient experienced an indi-
vidualised questionnaire, and additionally ensured that
patients were not asked large numbers of questions,
reducing the risk of questionnaire fatigue. Access to a copy
of the online questionnaire will be made available from the
authors on request.
The final data gathered was in relation to the patients’
experience of the online calculator and their opinions
regarding the need for such a service. Patients were
encouraged to leave suggestions about how the calculator
could be improved and their opinions about the use of a
website which may allow patients to monitor their disease
progression.
Statistical analysis
Statistical analysis was performed using JMP, Graphpad
(Prism 6) and PASW v18 (SPSS).
This study aimed to compare a web-based EDSS
assessment with the physician led EDSS. The non-para-
metric Kruskal-Wallis test was used and a one-way anal-
ysis of variance (ANOVA) was performed. The Bartlett
test is used to test whether the variances of the means are
equal or similar. The ANOVA generally assumes that the
variances are equal; hence, the Bartlett test is used to test
this assumption. [15] The EDSS is an ordinal variable,
thus, to measure agreement between the web-based and
physician EDSS and functional system scores, the kappa
coefficient and intra-class correlation coefficient were used.
[10] The kappa coefficient was used to examine the degree
of inter-observer agreement, and the intra-class correlation
co-efficient used to demonstrate overall agreement between
the two methods of assessment.
Results
Eighty-one patients were enrolled; 29 with primary pro-
gressive MS, 5 with relapsing progressive, and 47 with
relapsing-remitting MS. The EDSS at the time of data
collection ranged from 0 to 8. The group consisted of 49
women and 39 men; the average age was 41.5 years (range
18–68) (Table 1). EDSS from previous visit scores ranged
from 0 to 8.5 (Fig. 1). The mean duration of disease was
6.6 years (range \1–29 years). All patients carried out the
web-based survey with minimal assistance. Full EDSS
scores were available for 78 patients.
The web-EDSS score showed good agreement with the
physician (or actual) EDSS (Fig. 2). The Pearson’s
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correlation coefficient was 0.85. Figure 2 depicts the rela-
tionship between the actual (or physician-led) EDSS and
the differences between the means of the actual and web-
based method. One-way ANOVA showed EDSS and web
assessment agreement was best at scores \2.5 and [4.5,
with more than 50 % patients showing a difference of
0.5–1.
There was a significant difference in the mean results
between the score categories when using ANOVA.
However, when a match-paired test (Kruskal-Wallis) was
applied, the result was less conclusive, with a Chi square
of 0.068 indicating no significant difference between the
means. Additionally, the Bartlett test demonstrated no
significant difference between the variations of the
scoring groups. The mean of the difference in EDSS
scores was 0.46, and when the web-EDSS score was
adjusted by 0.4 there was no significant difference
between the means.
Weighted kappa for full agreement was 0.647. Full
agreement was observed in 20 patients who had EDSS
scores ranging from 0 to 6, most of those with 100 %
agreement had scores of 5.5–6 (n = 8). EDSS scores
within ±0.5 (n = 19) demonstrated a weighted kappa of
0.869 representing almost perfect agreement. However,
EDSS scores within ±1.0 (n = 15) had a weighted kappa
of 0.09, showing poor agreement. Six patients had scores
with a difference of ±1.5, seven a difference of ±2, five a
difference of ±3 and one a difference of 4. The intra-class
coefficient was 0.844 overall for all cases. It was 0.50 for
patients with an EDSS\4.0 and 0.52 for EDSS[4.0. This
is consistent with the findings shown in Fig. 2.
Functional system (FS) comparison was available for 52
patients. Weighted kappa values for visual, brainstem, pyra-
midal, cerebellar, sensory, bowel/bladder, and cerebral were
0.26, 0.238, 0.621, 0.532, 0.443, 0.586 and 0.526, respec-
tively. The intra-class coefficient showed the best correlation
in the pyramidal and bowel/bladder systems with scores of
0.78 and 0.75, respectively. Poor correlation was found for
Brainstem and Visual FS (ICC 0.19 and 0.25) (Table 2).
Taking mental impairment into account, there were 35
patients with a cerebral/mental FS equal to 0, 5 patients with a
score of 1, and 12 with a score of 2, as rated by their assessing
physician. The ICC for patients with a score of 0 was 0.805, for
those with a score of 1, 0.902 and, for those with significant
mental impairment, the ICC was found to be 0.696.
Fig. 1 Distribution of previous
(baseline) EDSS
Fig. 2 The actual EDSS plotted against the difference between the
means of physician or actual EDSS (P-EDSS) and web-based EDSS
(W-EDSS). The midpoint of the diamonds is the mean difference
between the two EDSS scores, the upper and lower lines within the
diamonds are the 95 % confidence interval. The width of the diamond
indicates the sample size, the dots the actual values. The horizontal
line at 0.46 indicates the mean difference between the two scores. The
graph indicates the greater variation at lower EDSS scores, with
greater agreement at scores [5
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Feedback from patients regarding the web-EDSS was
good. One hundred percent of the patients who started the
questionnaire completed it. All patients were able to
complete the questionnaire independently. The majority of
patients reported that the time taken to complete the
questionnaire was ‘‘just right’’, with the next most popular
answer ‘‘too short’’, indicating that patients did not feel
over-burdened by the questionnaire.
Discussion and conclusions
This study shows that the web-EDSS demonstrates good
agreement with the physician-measured EDSS in several
aspects of the assessment. To enable the results of this
study to be compared with others done on this subject, the
kappa coefficient and ICC were used. Exact agreement was
seen in 25 % of the patient group (Table 2).
The weighted kappa for overall agreement was 0.647,
which is considered to be good and is significantly better
than the values previously seen in the study of telephone-
based EDSS by Lechner-Scott et al. [11] (0.48) and in a
study using self-reported EDSS via questionnaire, carried
out by Cheung et al. [13] (0.43). When scores within ±0.5
EDSS steps were interpreted as being equivalent, the
weighted Kappa increased to 0.869, demonstrating almost
perfect agreement. It is important to consider these figures
in relation to agreement observed when the EDSS is carried
out by two different physicians. Amato et al. [4] investi-
gated the agreement between two physicians carrying out
EDSS assessment on patients with an EDSS range of
1.0–8.5 (i.e., a patient group comparable to ours) and found
the agreement to be 0.5. When half a point variation was
included the agreement was found to be 0.75. In this study
the physician-measured EDSS on average gives a lower
score, however, when a weighting factor of 0.4 is removed
there is a less significant difference between the two
methods of assessment. It is likely that data from a larger
group of patients is necessary to draw more definitive
conclusions on the web-EDSS as an exact comparison to
the physician measured EDSS.
Weighted kappa was lowest in the visual and brainstem
FS (0.26, 0.238) (Table 2). The poor agreement in visual
FS has been noted by Lechner-Scott et al. and by Cheung
et al. [13]. The authors suggest that the visual part of the
assessment can only be carried out accurately by a physi-
cian, due to the nature of the examination. Greatest
agreement was seen in the pyramidal and bowel/bladder
functional systems (0.62, 0.58). The moderate agreement
seen with the bowel/bladder systems is also observed by
Lechner-Scott et al. (0.42) and Cheung et al. (0.57).The
telephone-based study also demonstrated high levels of
agreement in the pyramidal FS (0.54) but unlike the web-
EDSS, the brainstem FS shows high levels of agreement
(0.59). The self-report study shows less agreement in the
pyramidal FS (0.34) and brainstem FS (0.31) [12].
It is likely that high levels of agreement are seen in the
bowel/bladder functional system due to the fact that this
component of the physician-rated EDSS is based on
directly asking the patient. Considering this, perhaps higher
levels of agreement should be expected. Interestingly more
than 90 % of those patients whose computer scores were
not equal to that assigned by their physician in the bowel/
bladder functional systems had higher scores from the web-
based assessment, possibly indicating that they perceived
their disability to be greater in these areas than the physi-
cian. A web-based assessment may be particularly useful
for patients who find it difficult to discuss problems relat-
ing to bowel, bladder and mental function. The cerebral FS
in the physician-based EDSS assessment is also generated
by questions directed to the patient by the physician, again
indicating that one would expect higher levels of agree-
ment. In this study the agreement was greater than that seen
in that of the telephone and self-reported methods of EDSS
assessment (0.526, 0.38, and 0.31, respectively).
The ICC was found to be 0.844 for the entire study
group, which indicates almost perfect agreement. A slight
increase in agreement was seen in patients with EDSS
scores [4.5; (n = 45) compared to those with scores \4.5
Table 1 Details of the patient group on whom full demographic data
were available (n = 62)
Demographic Number of
patients
Gender (M:F) 32:49
Age (mean; range; SD) 41.5, 24–59, 10.49
Duration of disease (since diagnosis)
(mean; SD)
6.6 years;
5.6 years
Type of MS (PPMS:RPMS:RRMS) 29:5:47
EDSS score (physician measured) (mean; range) 3.49; 2.31
Level of education (GCSE:A-
level:University:post grad:other)
14:8:33:3:4 (62)
Marital Status
(single:partner:married:separated:divorced)
20:5:30:2:5 (62)
Ethnicity (White-British:White-Irish:White-
Polish:White-Swedish:Indian:Afro-
Caribbean:British-Asian:White-other:White-
Black Caribbean)
50:2:2:1:2:1:1:1:1
(62)
Work status (full-time employment:part-
time:unemployed:self-employed:student
40:1:19:1:1 (62)
Hours worked (mean; SD) 25.4; 18.9
Number of relapses 2 years prior to diagnosis
(N/A:[5:4:3:2:1:0)
20:4:5:15:12:3: 3
(62)
Number of relapses in past 12 months
(N/A:[5:4:3:2:1:0)
18: 0: 1: 1: 0: 6:
36 (62)
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(n = 33); other studies have also noted a more significant
agreement in patients with greater disability. The increased
agreement in those with higher scores may be due to the
level of awareness patients with greater disability have
about their disease, or the more clear-cut boundaries
between EDSS steps.
As described by Amato et al. [4], the use of ‘self-
reported’ or patient-based methods of EDSS assessment
such as this web-based EDSS assessment tool appears to be
most useful for patients who demonstrate greater levels of
disability due to MS, rather than the relatively mild neu-
rological impairment seen in the early stages of disease. It
might also be a useful tool for stratifying patients according
to their perceived level of disability, allowing clinicians to
educate patients and to manage symptomatic aspects of
disease in association with the patients understanding of
their disability. A study by Van der Linden et al. [14]
investigated the use of patient proxy and self-assessment
with the MSIS-29. It found that on average the patient’s
carer or proxy viewed the patient’s disability as more
severe than the patient themselves did. However, the
overall level of agreement was good and this may be an
area which could be investigated with the web-based
EDSS. It could prove useful for patients with a very severe
level of disability.
As this is a pilot study of the web-based assessment tool,
clearly further work is required in a larger sample size to
validate the calculator. In addition its sensitivity to change
has not been explored. The EDSS as a form of disease
measurement has been criticised for its poor ability in this
regard; whether patient-based self-assessment might alter
this remains to be seen. Another potential advantage of the
web EDSS is the opportunity to expand the sections of the
scale that are less responsive to change, in particular in the
range from 5.5 to 7.0. We are currently exploring this
opportunity in addition to validating the calculator in a
larger patient cohort.
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